79
Views
46
CrossRef citations to date
0
Altmetric
Original Research

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells

, , , , , , , , , , , , , & show all
Pages 2373-2388 | Published online: 08 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Upal Roy, Hong Ding, Sudheesh Pilakka-Kanthikeel, Andrea D Raymond, Venkata Atluri, Adriana Yndart, Elena M Kaftanovskaya, Elena Batrakova, Marisela Agudelo & Madhavan Nair. (2015) Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue. International Journal of Nanomedicine 10, pages 5819-5835.
Read now
Theodore J Cory, Narasimha M Midde, PSS Rao & Santosh Kumar. (2015) Investigational reverse transcriptase inhibitors for the treatment of HIV. Expert Opinion on Investigational Drugs 24:9, pages 1219-1228.
Read now
Maria João Gomes, José das Neves & Bruno Sarmento. (2014) Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system. International Journal of Nanomedicine 9, pages 1757-1769.
Read now

Articles from other publishers (43)

Zachary F. Caffall, Bradley J. Wilkes, Ricardo Hernández-Martinez, Joseph E. Rittiner, Jennifer T. FoxKanny K. Wan, Miranda K. Shipman, Steven A. TitusYa-Qin ZhangSamarjit Patnaik, Matthew D. Hall, Matthew B. BoxerMin ShenZhuyin LiDavid E. Vaillancourt & Nicole Calakos. (2021) The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia. Science Translational Medicine 13:607.
Crossref
Katrin Hahn & Matthias Maschke. (2021) S1-Leitlinie: Diagnostik und Therapie HIV-1-assoziierter neurologischer ErkrankungenS1 guideline: diagnosis and treatment of HIV-1-associated neurological disorders. DGNeurologie 4:3, pages 165-183.
Crossref
Anupam Sarma & Malay K. Das. (2020) Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS. Molecular Biomedicine 1:1.
Crossref
Smita P. Kakad & Sanjay J. Kshirsagar. (2020) Neuro-AIDS: Current Status and Challenges to Antiretroviral Drug Therapy (ART) for Its Treatment. Current Drug Therapy 15:5, pages 469-481.
Crossref
Roberto De La Garza, Hansapani Rodrigo, Francisco Fernandez & Upal Roy. (2020) The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley. Current HIV Research 17:6, pages 377-387.
Crossref
Shijie Cao & Kim A. Woodrow. (2019) Nanotechnology approaches to eradicating HIV reservoirs. European Journal of Pharmaceutics and Biopharmaceutics 138, pages 48-63.
Crossref
Jonathan Herskovitz & Howard E. Gendelman. (2018) HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication. Journal of Neuroimmune Pharmacology 14:1, pages 52-67.
Crossref
Timothy M. Brenza, Benjamin W. Schlichtmann, Biju Bhargavan, Julia E. Vela Ramirez, Rainie D. Nelson, Matthew G. Panthani, JoEllyn M. McMillan, Balaraman Kalyanaraman, Howard E. Gendelman, Vellareddy Anantharam, Anumantha G. Kanthasamy, Surya K. Mallapragada, Balaji Narasimhan & Georgette D. Kanmogne. (2018) Biodegradable polyanhydride‐based nanomedicines for blood to brain drug delivery. Journal of Biomedical Materials Research Part A 106:11, pages 2881-2890.
Crossref
Ajeet Kaushik, Rahul D Jayant & Madhavan Nair. (2018) Nanomedicine for neuroHIV/AIDS management. Nanomedicine 13:7, pages 669-673.
Crossref
Adam S Mullis, Benjamin W Schlichtmann, Balaji Narasimhan, Rebecca Cademartiri & Surya K Mallapragada. (2018) Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeutics. Biomedical Materials 13:3, pages 034102.
Crossref
Brady Sillman, Christopher Woldstad, Joellyn Mcmillan & Howard E. Gendelman. 2018. The Neurology of HIV Infection. The Neurology of HIV Infection 21 40 .
Timothy M. Brenza, Shivani Ghaisas, Julia E. Vela Ramirez, Dilshan Harischandra, Vellareddy Anantharam, Balaraman Kalyanaraman, Anumantha G. Kanthasamy & Balaji Narasimhan. (2017) Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy. Nanomedicine: Nanotechnology, Biology and Medicine 13:3, pages 809-820.
Crossref
Luisa Fiandra, Amedeo Capetti, Luca Sorrentino & Fabio Corsi. (2016) Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art. Journal of Neuroimmune Pharmacology 12:1, pages 17-30.
Crossref
Clélia Dental, Alizé Proust, Michel Ouellet, Corinne Barat & Michel J. Tremblay. (2017) HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood–Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration. The Journal of Immunology 198:3, pages 1229-1241.
Crossref
Charurut Somboonwit, Jose A. Montero, John T. Sinnott & Paul Shapshak. 2017. Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS 405 434 .
Anita Leporati, Mikhail S. Novikov, Vladimir T. Valuev-Elliston, Sergey P. Korolev, Anastasia L. Khandazhinskaya, Sergey N. Kochetkov, Suresh Gupta, Julian Goding, Elijah Bolotin, Marina B. Gottikh & Alexei A. BogdanovJr.Jr.. (2016) Hydrophobic-core PEGylated graft copolymer-stabilized nanoparticles composed of insoluble non-nucleoside reverse transcriptase inhibitors exhibit strong anti-HIV activity. Nanomedicine: Nanotechnology, Biology and Medicine 12:8, pages 2405-2413.
Crossref
Malay K. Das, Anupam Sarma & Tapash Chakraborty. (2016) Nano-ART and NeuroAIDS. Drug Delivery and Translational Research 6:5, pages 452-472.
Crossref
Balaji NarasimhanJonathan T. GoodmanJulia E. Vela Ramirez. (2016) Rational Design of Targeted Next-Generation Carriers for Drug and Vaccine Delivery. Annual Review of Biomedical Engineering 18:1, pages 25-49.
Crossref
Andrea L. Martinez-Skinner, Mariluz A. Araínga, Pavan Puligujja, Diana L. Palandri, Hannah M. Baldridge, Benson J. Edagwa, JoEllyn M. McMillan, R. Lee Mosley & Howard E. Gendelman. (2015) Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. PLOS ONE 10:12, pages e0145966.
Crossref
R Verloes, S Deleu, N Niemeijer, H Crauwels, P Meyvisch & P Williams. (2015) Safety, tolerability and pharmacokinetics of rilpivirine following administration of a long-acting formulation in healthy volunteers. HIV Medicine 16:8, pages 477-484.
Crossref
Upal Roy, Venkata S. R. Atluri, Marisela Agudelo, Adriana Yndart, Zaohua Huang & Madhavan Nair. (2015) DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine. Frontiers in Microbiology 6.
Crossref
Giovanna Giacalone, Hervé Hillaireau & Elias Fattal. (2015) Improving bioavailability and biodistribution of anti-HIV chemotherapy. European Journal of Pharmaceutical Sciences 75, pages 40-53.
Crossref
Howard E. Gendelman, Vellareddy Anantharam, Tatiana Bronich, Shivani Ghaisas, Huajun Jin, Anumantha G. Kanthasamy, Xinming Liu, JoEllyn McMillan, R. Lee Mosley, Balaji Narasimhan & Surya K. Mallapragada. (2015) Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine: Nanotechnology, Biology and Medicine 11:3, pages 751-767.
Crossref
Surya K. Mallapragada, Timothy M. Brenza, JoEllyn M. McMillan, Balaji Narasimhan, Donald S. Sakaguchi, Anup D. Sharma, Svitlana Zbarska & Howard E. Gendelman. (2015) Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines. Nanomedicine: Nanotechnology, Biology and Medicine 11:3, pages 715-729.
Crossref
Supriya D. Mahajan, Ravikumar Aalinkeel, Jessica L. Reynolds, Bindukumar B. Nair, Manoj J. Mammen, Lili Dai, Paras N. Prasad & Stanley A. Schwartz. 2015. Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases. Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases 251 268 .
Dorothy E. Dow & John A. Bartlett. (2014) Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV. Infectious Diseases and Therapy 3:2, pages 83-102.
Crossref
Dongwei Guo, Tianyuzi Li, JoEllyn McMillan, Balasrinivasa R Sajja, Pavan Puligujja, Michael D Boska, Howard E Gendelman & Xin-Ming Liu. (2014) Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution. Nanomedicine 9:9, pages 1341-1352.
Crossref
Vidya Sagar, Sudheesh Pilakka-Kanthikeel, Ravi Pottathil, Shailendra K. Saxena & Madhavan Nair. (2014) Towards nanomedicines for neuroAIDS. Reviews in Medical Virology 24:2, pages 103-124.
Crossref
Tom O. McDonald, Marco Giardiello, Philip Martin, Marco Siccardi, Neill J. Liptrott, Darren Smith, Phill Roberts, Paul Curley, Alessandro Schipani, Saye H. Khoo, James Long, Alison J. Foster, Steven P. Rannard & Andrew Owen. (2014) Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro-In Vivo Correlation. Advanced Healthcare Materials 3:3, pages 400-411.
Crossref
André NelSusan Swindells, Tatiana Bronich & Howard E Gendelman. (2014) Interview: Nanomedicine and the fight against HIV/AIDS. Nanomedicine 9:2, pages 193-206.
Crossref
JoEllyn M. McMillan & Howard E. Gendelman. 2014. Humanized Mice for HIV Research. Humanized Mice for HIV Research 381 396 .
JoEllyn M. McMillan & Howard E. Gendelman. 2014. Neuroinflammation and Neurodegeneration. Neuroinflammation and Neurodegeneration 529 546 .
JoEllyn M. McMillan, Xin-Ming Liu & Howard E. Gendelman. 2014. Current Laboratory Methods in Neuroscience Research. Current Laboratory Methods in Neuroscience Research 223 231 .
Xin-Ming Liu & Tatiana K. Bronich. 2014. Current Laboratory Methods in Neuroscience Research. Current Laboratory Methods in Neuroscience Research 213 222 .
Santhi Gorantla, Myhanh Che & Howard E. Gendelman. 2014. Current Laboratory Methods in Neuroscience Research. Current Laboratory Methods in Neuroscience Research 165 175 .
Jennifer Williams, Harlan R Sayles, Jane L Meza, Patrick Sayre, Uriel Sandkovsky, Howard E Gendelman, Charles Flexner & Susan Swindells. (2013) Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients. Nanomedicine 8:11, pages 1807-1813.
Crossref
Pavan Puligujja, JoEllyn McMillan, Lindsey Kendrick, Tianyuzi Li, Shantanu Balkundi, Nathan Smith, Ram S. Veerubhotla, Benson J. Edagwa, Alexander V. Kabanov, Tatiana Bronich, Howard E. Gendelman & Xin-Ming Liu. (2013) Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections. Nanomedicine: Nanotechnology, Biology and Medicine 9:8, pages 1263-1273.
Crossref
Nagsen Gautam, Upal Roy, Shantanu Balkundi, Pavan Puligujja, Dongwei Guo, Nathan Smith, Xin-Ming Liu, Benjamin Lamberty, Brenda Morsey, Howard S. Fox, JoEllyn McMillan, Howard E. Gendelman & Yazen Alnouti. (2013) Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy. Antimicrobial Agents and Chemotherapy 57:7, pages 3110-3120.
Crossref
Andrea L. Martinez-Skinner, Ram S. Veerubhotla, Han Liu, Huangui Xiong, Fang Yu, JoEllyn M. McMillan & Howard E. Gendelman. (2013) Functional Proteome of Macrophage Carried Nanoformulated Antiretroviral Therapy Demonstrates Enhanced Particle Carrying Capacity. Journal of Proteome Research 12:5, pages 2282-2294.
Crossref
Theodore J. Cory, Timothy W. Schacker, Mario Stevenson & Courtney V. Fletcher. (2013) Overcoming pharmacologic sanctuaries. Current Opinion in HIV and AIDS 8:3, pages 190-195.
Crossref
Franziska Bahring, Florian Schlenk, Jana Wotschadlo, Norbert Buske, Tim Liebert, Christian Bergemann, Thomas Heinze, Andreas Hochhaus, Dagmar Fischer & Joachim H. Clement. (2013) Suitability of Viability Assays for Testing Biological Effects of Coated Superparamagnetic Nanoparticles. IEEE Transactions on Magnetics 49:1, pages 383-388.
Crossref
Prasanta K. Dash, Howard E. Gendelman, Upal Roy, Shantanu Balkundi, Yazen Alnouti, Rodney L. Mosley, Harris A. Gelbard, JoEllyn McMillan, Santhi Gorantla & Larisa Y. Poluektova. (2012) Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. AIDS 26:17, pages 2135-2144.
Crossref
Howard S. Fox & Howard E. Gendelman. (2012) Commentary: Animal Models of NeuroAIDS. Journal of Neuroimmune Pharmacology 7:2, pages 301-305.
Crossref